Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Greenwich Global Hedge Fund Index ends January down -0.73%

Saturday, February 22, 2014
Opalesque Industry Update - The Greenwich Global Hedge Fund Index ended the month of January down -0.73%. The month saw different performance results for stocks versus bonds. Global equity markets dropped over doubts about the stability of some emerging market currencies but credit markets improved from a flight to quality. Equity markets as measured by the S&P500 were down -3.46%, the MSCI World, down -3.77% and the MSCI Emerging Markets Index, down -6.60% in January, 2014. Credit markets as measured by the Barclay Aggregate Index were up 1.48%.

Global Hedge Fund Index Strategy Highlights

- Short-Biased equity funds were the best performing strategy in January posting a gain of +3.04%.
- Credit funds showed positive returns with Fixed Income Arbitrage up 1.05%, followed by Convertible Arbitrage up .93% and Long/Short Credit up 29%.
- Long/Short equity funds suffered along with the equity markets with value oriented funds down -1.45% and growth down -1.22%.
- Futures funds were the worst performing strategy down -1.67% resulting from the rapid market trend changes in January.

Press release

www.greenwichai.com

Bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its